Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Tepadina 100mg


Contraindicated
Embryo-foetal death

Contraindicated
Tepadina 100mg :
Type Medicine Authorised
Originator G
Agent Pharmamed
Distributor Pharmamed
Laboratory Adienne
Responsible Party Adienne SA
Origin Switzerland
Manufacturer BSP Pharmaceuticals SRL
Origin Italy
ATC L01AC01

Your comment will appear shortly after approval

Tepadina 100mg :

Revision Date : 14/09/2021


Effect Frequency
Abdominal pain Very Common
Acute graft versus host disease Very Common
Agitation Uncommon
Alopecia Very Common
Amenorrhoea (amenorrhea) Very Common
Anaemia Very Common
Anorexia Very Common
Anxiety Common
Arrhythmia Very Common
Arthralgia (Pain joint) (Joint ache) Very Common
AST increased Common
Asthenia Very Common
Azoospermia Very Common
Back pain Very Common
Blood alkaline phosphatase increased Common
Blood amylase increased Very Common
Blood bilirubin increased Very Common
Blood creatinine increased Common
Blood urea increased Common
Cardiac failure Common
Cardiomyopathy Uncommon
Cataract Common
Cerebral haemorrhage Common
Chills Very Common
Chronic graft versus host disease Very Common
Cognitive disorder Common
Colitis Very Common
Confusional state Very Common
Conjunctivitis Very Common
Constipation Common
Convulsion Very Common
Cough Common
Cystitis Common
Cystitis haemorrhagic Very Common
Decreased appetite Very Common
Delirium Uncommon
Diarrhoea (Diarrhea) Very Common
Dizziness Very Common
Dyspepsia Very Common
Dysuria (Micturition painful) Common
Embolism Common
Encephalopathy Very Common
Enteritis Very Common
Epistaxis (Nasal bleeding) Very Common
Erythema Common
Erythrodermic psoriasis Uncommon
Extrapyramidal disorder Common
Febrile neutropenia (Neutropenic fever) Very Common
Gamma-GT increased Common
Gastrointestinal perforation Common
Gastrointestinal ulcer Uncommon
Generalized oedema Very Common
Granulocytopenia Very Common
Haematuria (Hematuria) Common
Haemorrhage Common
Hallucination Uncommon
Headache Very Common
Hearing impaired Very Common
Hepatomegaly Very Common
Hyperglycaemia Very Common
Hypersensitivity Common
Hypertension Very Common
Hypopituitarism Common
Hypoxia Uncommon
Idiopathic pneumonia syndrome Very Common
Ileus Common
Infection Very Common
Infertility female Common
Infertility male Common
Injection site inflammation Very Common
Injection site pain Very Common
Intracranial aneurysm Common
Jaundice Very Common
Leucopenia (Leukopenia) Very Common
Leukoencephalopathy Not known
Lyell Syndrome (Toxic epidermal necrolysis) Not known
Lymphoedema Very Common
Menopausal symptoms Common
Mental status changes Very Common
Mucosal inflammation Very Common
Multi-organ failure Common
Myalgia Very Common
Myocarditis Uncommon
Nausea Very Common
Nervousness Uncommon
Oesophagitis Very Common
Oliguria Common
Ototoxicity Very Common
Pain Common
Pancytopenia Very Common
Paraesthesia (paresthesia) Very Common
Pigmentation disorder Uncommon
Pneumonitis Common
Pruritus Very Common
Pulmonary oedema Common
Pyrexia Very Common
Renal failure Common
Skin rash Very Common
Stevens-Johnson syndrome Not known
Stomatitis Very Common
Tachycardia Common
Thrombocytopenia (Thrombopenia) Very Common
Tinnitus Very Common
Toxic shock syndrome Uncommon
Transaminases increased Very Common
Treatment related second malignancy Common
Vaginal haemorrhage Very Common
Venoocclusive liver disease Very Common
Vision blurred Very Common
Vomiting Very Common
Weight increased (weight gain) Very Common

Different Units By MoH Code

Tepadina 100mg  MoH 10785 :
Form Powder for concentrate for solution for infusion
Packaging Vial (Type I Glass)
Package Size Box of 1
Strength 100mg
Storage Condition 2-8°C Do not freeze
Public Price 1610675 L.L.
Stratum E2
NSSF ✘
Quarantine ✘
Reg. Number 94421/1
Submission date 30/07/2021
Registration Year 04/01/2022


Price Comparison

● Country: Denmark
● Package Size: 1
● Public Price: 20235.65 DKK ( 262,577,794.40 LBP )
● Pack size unit used: 1
● Cost/Unit: 20235,65 DKK ( 262,569,360.00 LBP )
● Pharmacy Price: 15040 DKK ( 195159040 LBP )
● Reference: Danish Medicine Agency
● Pricing Date: 19/05/2021
● Type: Medicine Authorised

● Country: Finland
● Package Size: 1
● Public Price: 1344.7 EUR ( 130,269,157.20 LBP )
● Pack size unit used: 1
● Cost/Unit: 1344,7 EUR ( 130,201,344.00 LBP )
● Reference: Kela
● Pricing Date: 08/01/2022
● Type: Medicine Authorised

● Country: Italy
● Package Size: 10ml
● Public Price: 1277.08 EUR ( 123,718,402.08 LBP )
● Pack size unit used: 1
● Cost/Unit: 1277,08 EUR ( 123,710,652.00 LBP )
● Exfactory Price: 773.44 EUR
● Pricing Date: 17/12/2019
● Type: Medicine Authorised

● Country: Cyprus
● Package Size: 1
● Public Price: 974.84 EUR ( 94,438,599.84 LBP )
● Pack size unit used: 1
● Cost/Unit: 974,84 EUR ( 94,357,224.00 LBP )
● Reference: Cyprus Minister of Health
● Pricing Date: 24/03/2021
● Type: Medicine Authorised

● Country: UK
● Package Size: 1
● Public Price: 736 GBP ( 83,645,664.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 736 GBP ( 83,645,664.00 LBP )
● Reference: DMD
● Pricing Date: 08/03/2021
● Type: Medicine Authorised

● Country: Belgium
● Package Size: 1
● Public Price: 859 EUR ( 83,216,484.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 859 EUR ( 83,216,484.00 LBP )
● Reference: cbip
● Pricing Date: 08/01/2022
● Type: Medicine Authorised

● Country: Norway
● Package Size: 1
● Public Price: 10090.3 NOK ( 81,771,791.20 LBP )
● Pack size unit used: 1
● Cost/Unit: 10090,3 NOK ( 81,769,360.00 LBP )
● Pharmacy Price: 7847.1 NOK ( 63592898.4 LBP )
● Reference: Norwegian Medicine Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

● Country: Czech Republic
● Package Size: 1
● Public Price: 20247.13 CZK ( 77,323,789.47 LBP )
● Pack size unit used: 1
● Cost/Unit: 20247,13 CZK ( 77,323,293.00 LBP )
● Reference: SUKL
● Pricing Date: 28/02/2020
● Type: Medicine Authorised

● Country: Lebanon
● Form: Powder for concentrate for solution for infusion
● Package Size: Box of 1
● Public Price: 1610675 LBP ( 1,610,675.00 LBP )
● Pack size unit used: 1
● Cost/Unit: 1610675 LBP ( 1,610,675.00 LBP )
● Pricing Date: 13/06/2024

● Country: The Netherlands
● Package Size: 1
● Reference: Zorginstituut Nederland
● Pricing Date: 15/06/2019
● Type: Medicine Authorised

● Country: New Zealand
● Package Size: 1 inj
● Reference: New Zealand Pharmaceutical Management Agency
● Pricing Date: 01/01/2019
● Type: Medicine Non Marketed

● Country: France
● Package Size: 1
● Reference: ansm
● Pricing Date: 15/05/2021
● Type: Medicine Authorised

● Country: Spain
● Package Size: 1 vial
● Reference: Agencia Española de Medicamentos y Productos Sanitarios
● Pricing Date: 06/05/2021
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

Conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases : (Adults)
● Cost/Unit: 20235,65 DKK ( 262,569,360.00 LBP )
● Cost/Day: 20235,65 DKK ( 262,569,360.00 LBP )
● Cost/Month: 60706,95 DKK ( 787,721,056.00 LBP )
Conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases : (Children)
● Cost/Unit: 20235,65 DKK ( 262,569,360.00 LBP )
● Cost/Day: 20235,65 DKK ( 262,569,360.00 LBP )
● Cost/Month: 60706,95 DKK ( 787,721,056.00 LBP )
High dose chemotherapy with HPCT support for the treatment of solid tumours : (Children)
● Cost/Unit: 20235,65 DKK ( 262,569,360.00 LBP )
● Cost/Day: 20235,65 DKK ( 262,569,360.00 LBP )
● Cost/Month: 60706,95 DKK ( 787,721,056.00 LBP )
High dose chemotherapy with HPCT support for the treatment of solid tumours : (Adults)
● Cost/Unit: 20235,65 DKK ( 262,569,360.00 LBP )
● Cost/Day: 20235,65 DKK ( 262,569,360.00 LBP )
● Cost/Month: 60706,95 DKK ( 787,721,056.00 LBP )
Conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases : (Adults)
● Cost/Unit: 1344,7 EUR ( 130,201,344.00 LBP )
● Cost/Day: 1344,7 EUR ( 130,201,344.00 LBP )
● Cost/Month: 4034,1 EUR ( 390,797,784.00 LBP )
Conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases : (Children)
● Cost/Unit: 1344,7 EUR ( 130,201,344.00 LBP )
● Cost/Day: 1344,7 EUR ( 130,201,344.00 LBP )
● Cost/Month: 4034,1 EUR ( 390,797,784.00 LBP )
High dose chemotherapy with HPCT support for the treatment of solid tumours : (Children)
● Cost/Unit: 1344,7 EUR ( 130,201,344.00 LBP )
● Cost/Day: 1344,7 EUR ( 130,201,344.00 LBP )
● Cost/Month: 4034,1 EUR ( 390,797,784.00 LBP )
High dose chemotherapy with HPCT support for the treatment of solid tumours : (Adults)
● Cost/Unit: 1344,7 EUR ( 130,201,344.00 LBP )
● Cost/Day: 1344,7 EUR ( 130,201,344.00 LBP )
● Cost/Month: 4034,1 EUR ( 390,797,784.00 LBP )
Conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases : (Adults)
● Cost/Unit: 1277,08 EUR ( 123,710,652.00 LBP )
● Cost/Day: 1277,08 EUR ( 123,710,652.00 LBP )
● Cost/Month: 3831,24 EUR ( 371,131,956.00 LBP )
Conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases : (Children)
● Cost/Unit: 1277,08 EUR ( 123,710,652.00 LBP )
● Cost/Day: 1277,08 EUR ( 123,710,652.00 LBP )
● Cost/Month: 3831,24 EUR ( 371,131,956.00 LBP )
High dose chemotherapy with HPCT support for the treatment of solid tumours : (Children)
● Cost/Unit: 1277,08 EUR ( 123,710,652.00 LBP )
● Cost/Day: 1277,08 EUR ( 123,710,652.00 LBP )
● Cost/Month: 3831,24 EUR ( 371,131,956.00 LBP )
High dose chemotherapy with HPCT support for the treatment of solid tumours : (Adults)
● Cost/Unit: 1277,08 EUR ( 123,710,652.00 LBP )
● Cost/Day: 1277,08 EUR ( 123,710,652.00 LBP )
● Cost/Month: 3831,24 EUR ( 371,131,956.00 LBP )
Conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases : (Adults)
● Cost/Unit: 974,84 EUR ( 94,357,224.00 LBP )
● Cost/Day: 974,84 EUR ( 94,357,224.00 LBP )
● Cost/Month: 2924,52 EUR ( 283,265,424.00 LBP )
Conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases : (Children)
● Cost/Unit: 974,84 EUR ( 94,357,224.00 LBP )
● Cost/Day: 974,84 EUR ( 94,357,224.00 LBP )
● Cost/Month: 2924,52 EUR ( 283,265,424.00 LBP )
High dose chemotherapy with HPCT support for the treatment of solid tumours : (Children)
● Cost/Unit: 974,84 EUR ( 94,357,224.00 LBP )
● Cost/Day: 974,84 EUR ( 94,357,224.00 LBP )
● Cost/Month: 2924,52 EUR ( 283,265,424.00 LBP )
High dose chemotherapy with HPCT support for the treatment of solid tumours : (Adults)
● Cost/Unit: 974,84 EUR ( 94,357,224.00 LBP )
● Cost/Day: 974,84 EUR ( 94,357,224.00 LBP )
● Cost/Month: 2924,52 EUR ( 283,265,424.00 LBP )
Conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases : (Adults)
● Cost/Unit: 736 GBP ( 83,645,664.00 LBP )
● Cost/Day: 736 GBP ( 83,645,664.00 LBP )
● Cost/Month: 2208 GBP ( 250,936,992.00 LBP )
Conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases : (Children)
● Cost/Unit: 736 GBP ( 83,645,664.00 LBP )
● Cost/Day: 736 GBP ( 83,645,664.00 LBP )
● Cost/Month: 2208 GBP ( 250,936,992.00 LBP )
High dose chemotherapy with HPCT support for the treatment of solid tumours : (Children)
● Cost/Unit: 736 GBP ( 83,645,664.00 LBP )
● Cost/Day: 736 GBP ( 83,645,664.00 LBP )
● Cost/Month: 2208 GBP ( 250,936,992.00 LBP )
High dose chemotherapy with HPCT support for the treatment of solid tumours : (Adults)
● Cost/Unit: 736 GBP ( 83,645,664.00 LBP )
● Cost/Day: 736 GBP ( 83,645,664.00 LBP )
● Cost/Month: 2208 GBP ( 250,936,992.00 LBP )
Conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases : (Adults)
● Cost/Unit: 859 EUR ( 83,216,484.00 LBP )
● Cost/Day: 859 EUR ( 83,216,484.00 LBP )
● Cost/Month: 2577 EUR ( 249,649,452.00 LBP )
Conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases : (Children)
● Cost/Unit: 859 EUR ( 83,216,484.00 LBP )
● Cost/Day: 859 EUR ( 83,216,484.00 LBP )
● Cost/Month: 2577 EUR ( 249,649,452.00 LBP )
High dose chemotherapy with HPCT support for the treatment of solid tumours : (Children)
● Cost/Unit: 859 EUR ( 83,216,484.00 LBP )
● Cost/Day: 859 EUR ( 83,216,484.00 LBP )
● Cost/Month: 2577 EUR ( 249,649,452.00 LBP )
High dose chemotherapy with HPCT support for the treatment of solid tumours : (Adults)
● Cost/Unit: 859 EUR ( 83,216,484.00 LBP )
● Cost/Day: 859 EUR ( 83,216,484.00 LBP )
● Cost/Month: 2577 EUR ( 249,649,452.00 LBP )
Conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases : (Adults)
● Cost/Unit: 10090,3 NOK ( 81,769,360.00 LBP )
● Cost/Day: 10090,3 NOK ( 81,769,360.00 LBP )
● Cost/Month: 30270,9 NOK ( 245,308,080.00 LBP )
Conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases : (Children)
● Cost/Unit: 10090,3 NOK ( 81,769,360.00 LBP )
● Cost/Day: 10090,3 NOK ( 81,769,360.00 LBP )
● Cost/Month: 30270,9 NOK ( 245,308,080.00 LBP )
High dose chemotherapy with HPCT support for the treatment of solid tumours : (Children)
● Cost/Unit: 10090,3 NOK ( 81,769,360.00 LBP )
● Cost/Day: 10090,3 NOK ( 81,769,360.00 LBP )
● Cost/Month: 30270,9 NOK ( 245,308,080.00 LBP )
High dose chemotherapy with HPCT support for the treatment of solid tumours : (Adults)
● Cost/Unit: 10090,3 NOK ( 81,769,360.00 LBP )
● Cost/Day: 10090,3 NOK ( 81,769,360.00 LBP )
● Cost/Month: 30270,9 NOK ( 245,308,080.00 LBP )
Conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases : (Adults)
● Cost/Unit: 20247,13 CZK ( 77,323,293.00 LBP )
● Cost/Day: 20247,13 CZK ( 77,323,293.00 LBP )
● Cost/Month: 60741,39 CZK ( 231,969,879.00 LBP )
Conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases : (Children)
● Cost/Unit: 20247,13 CZK ( 77,323,293.00 LBP )
● Cost/Day: 20247,13 CZK ( 77,323,293.00 LBP )
● Cost/Month: 60741,39 CZK ( 231,969,879.00 LBP )
High dose chemotherapy with HPCT support for the treatment of solid tumours : (Children)
● Cost/Unit: 20247,13 CZK ( 77,323,293.00 LBP )
● Cost/Day: 20247,13 CZK ( 77,323,293.00 LBP )
● Cost/Month: 60741,39 CZK ( 231,969,879.00 LBP )
High dose chemotherapy with HPCT support for the treatment of solid tumours : (Adults)
● Cost/Unit: 20247,13 CZK ( 77,323,293.00 LBP )
● Cost/Day: 20247,13 CZK ( 77,323,293.00 LBP )
● Cost/Month: 60741,39 CZK ( 231,969,879.00 LBP )
Conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases : (Adults)
● Cost/Unit: 1610675 LBP ( 1,610,675.00 LBP )
● Cost/Day: 1610675 LBP ( 1,610,675.00 LBP )
● Cost/Month: 4832025 LBP ( 4,832,025.00 LBP )
Conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases : (Children)
● Cost/Unit: 1610675 LBP ( 1,610,675.00 LBP )
● Cost/Day: 1610675 LBP ( 1,610,675.00 LBP )
● Cost/Month: 4832025 LBP ( 4,832,025.00 LBP )
High dose chemotherapy with HPCT support for the treatment of solid tumours : (Children)
● Cost/Unit: 1610675 LBP ( 1,610,675.00 LBP )
● Cost/Day: 1610675 LBP ( 1,610,675.00 LBP )
● Cost/Month: 4832025 LBP ( 4,832,025.00 LBP )
High dose chemotherapy with HPCT support for the treatment of solid tumours : (Adults)
● Cost/Unit: 1610675 LBP ( 1,610,675.00 LBP )
● Cost/Day: 1610675 LBP ( 1,610,675.00 LBP )
● Cost/Month: 4832025 LBP ( 4,832,025.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info